Designing What Works:
From Policy Intent to Health
System Reality
Thursday, May 28, 2026
Divani Caravel Hotel , Macedonia Hall
Where Greece’s healthcare decision-makers meet to define what truly works – aligning policy, governance, financing, and innovation to build resilient and high-performing health systems for the future.
Healthcare is entering a decisive phase. At a pivotal stage for European and national health systems, reform demands more than vision – it is no longer theoretical; it is operational.
The Future of Healthcare in Greece Conference 2026 moves beyond discussion to focus on implementation, measurable impact, and structural transformation. At a critical juncture for Greek healthcare, the conference brings together policymakers, regulators, institutional leaders, healthcare providers, and industry stakeholders to examine how policy intent translates into tangible health system reality.
Under this year’s theme, “Designing what Works: From Policy Intent to Health System Reality,” the conference addresses the hard choices shaping the sustainability of the Greek health system, explores how pharmaceutical innovation, real-world evidence, and value-based financing can accelerate access to new therapies, and highlights the workforce and digital capacity required to deliver long-term reform in the Greek healthcare ecosystem.
The 2026 edition positions itself as a high-level strategic platform aligned with European health policy priorities, bringing together public and private stakeholders – including the pharmaceutical and MedTech industry – committed to advancing a sustainable, innovative, and patient-centred healthcare system in Greece.
Main Sessions of the Conference
Health in a Shifting World: Geopolitics, Energy and System Resilience
Exploring how geopolitical developments, energy instability, and global disruptions are reshaping healthcare systems, influencing access, supply chains, and long-term system resilience.
Healthcare as a Catalyst for Growth: Optimizing Healthcare Delivery
Highlighting the role of healthcare as a driver of economic growth, focusing on efficiency, system performance, and the optimization of care delivery models.
From Regulation to Reality: The EU Pharma Package and its Impact on National Systems
Assessing how the evolving European pharmaceutical framework is shaping access, innovation, and regulatory alignment at the national level.
Sustainability of Private Healthcare & Insurance Markets: Bridging the Gap between Care and Coverage
Examining the sustainability of private healthcare and insurance markets, and their role in improving access, affordability, and continuity of care.
Financing the Future of Care: Value, Innovation & the Clawback Dilemma
Exploring the financial architecture required to sustain reform and ensure access to innovation; Clawback sustainability & reform pathway; Outcome-based reimbursement; EU HTA Regulation implementation; Examining market access pathways; RRF investments in healthcare infrastructure
The Chronic Disease Challenge: Prevention, Innovation and System Sustainability
Addressing the growing prevalence of chronic and age-related conditions in Greece and the role of innovative therapies, prevention programmes, and integrated care pathways in reducing long-term system costs.
MedTech & Innovation: Unlocking Growth under Cost-Containment Pressures
Focusing on the role of medical technology and innovation in improving outcomes, while navigating budget constraints and cost-containment policies.
Speakers
Why Attend?
- Gain insight into national reform priorities and policy direction
- Understand reimbursement evolution and financing sustainability
- Explore innovation pathways aligned with regulatory frameworks
- Navigate pharma market access, pricing, and reimbursement frameworks in the Greek context
- Identify collaboration opportunities across public and private sectors
- Position your organization within the evolving healthcare landscape
Who should Attend?
- Government officials & policymakers
- Regulatory authorities
- Health system administrators
- Hospital and clinical leaders
- Pharmaceutical & MedTech executives
- Digital health & technology leaders
- Health insurers and payers
- Academic & research institutions
- Patient advocacy representatives
- Investment and advisory professionals in healthcare
Express Your Interest
Fill out the interest form to be the first to know about ticket packages and sponsorship opportunities.
Sponsors
Since 1965, ELPEN is a leading company in the Greek pharmaceutical market with a strong international footprint. It is active in the production of high quality Greek medicines and it invests 15% of its annual turnover in Research. ELPEN’s products are exported to more than 90 countries, while it maintains subsidiaries in Berlin and Dubai. Today, its workforce exceeds 1,700 employees.
VIA IQ (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 70,000 employees worldwide. Learn more at iqvia.com.
KALTEQ S.A. brings over 20 years of proven expertise in the medical technology sector.
Our portfolio spans a wide range of specialties, including General Surgery, Neurosurgery, ENT, Orthopedic Surgery, Cardiac Surgery, Interventional Radiology, Neuroradiology, Trauma, Wound Management, Ophthalmology, and Pain Management—ensuring comprehensive coverage of modern clinical needs. Headquartered in Athens, KALTEQ S.A. operates an extensive network of branches in Thessaloniki, Heraklion, Patras, Larissa, and Nicosia, while maintaining a strong and growing presence across Southeastern Europe and the Balkans.
Medtronic plc, headquartered in Dublin, Ireland, is a global leader in medical technology, employing over 90,000 people and operating in 160+ countries. Its focus includes cardiovascular, diabetes, minimally invasive therapies, and rehabilitation. Active in Greece since 1997, Medtronic Hellas employs 150+ in Athens and Thessaloniki, driving healthcare transformation through innovative therapies and playing a pivotal role in the industry.
